Nanomaterial Consumer Products and FDA Regulation:
Regulatory Challenges and Necessary Amendments
Volume 3, Issue 3
George A. Kimbrell, International Center for Technology Assessment
Consumer products composed of nanomaterials have arrived and represent the crest of a product wave spanning many technologies. Hundreds of nano-products are already widely available, and are particularly prevalent in the personal care product sector. The FDA has regulatory authority over many of these products; however as of yet it has taken no action to account for the fundamentally different properties and associated risks of their nanomaterial ingredients. This article evaluates the FDA’s current regulatory stance on nanomaterial consumer products. The author then discusses the recent legal petition filed by his organization and others calling for the FDA to amend its regulations to address the human health and environmental risks posed by nanomaterial products.
Full Text (PDF)